1-5 of 5
Edwin P. Alyea, III
Close
Sort by
Journal Articles

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease

Clinical Trials & Observations
Jennifer S. Whangbo, Sarah Nikiforow, Haesook T. Kim, Jonathan Wahl, Carol G. Reynolds, Sharmila C. Rai, Soomin Kim, Andrew Burden, Ana C. Alho, João F. Lacerda, Edwin P. Alyea, III, Corey S. Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5786–5796.
https://doi.org/10.1182/bloodadvances.2021006625
Published: 2022
Includes: Supplemental data
Journal Articles

GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial

Clinical Trials & Observations
Vincent T. Ho, Haesook T. Kim, Jennifer Brock, Ilene Galinsky, Heather Daley, Carol Reynolds, Augustine Weber, Olga Pozdnyakova, Mariano Severgnini, Sarah Nikiforow, Corey Cutler, John Koreth, Edwin P. Alyea, III, Joseph H. Antin, Mahasweta Gooptu, Rizwan Romee, Roman Shapiro, Yi-Bin Chen, Jacalyn Rosenblatt, David Avigan, F. Stephen Hodi, Glenn Dranoff, Catherine J. Wu, Jerome Ritz, Robert J. Soiffer
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2183–2194.
https://doi.org/10.1182/bloodadvances.2021006255
Published: 2022
Includes: Supplemental data
Journal Articles

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

Clinical Trials & Observations
Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2550–2561.
https://doi.org/10.1182/bloodadvances.2019000631
Published: 2019
Includes: Supplemental data
Journal Articles

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, III, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2199–2204.
https://doi.org/10.1182/bloodadvances.2019000445
Published: 2019
Includes: Supplemental data
Journal Articles

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease

Clinical Trials & Observations
Jennifer S. Whangbo, Haesook T. Kim, Sarah Nikiforow, John Koreth, Ana C. Alho, Bryn Falahee, Soomin Kim, Katharine Dusenbury, Marie J. Fields, Carol G. Reynolds, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz
Journal: Blood Advances
Blood Adv (2019) 3 (7): 984–994.
https://doi.org/10.1182/bloodadvances.2018027474
Published: 2019
Includes: Supplemental data